NIKAOTCPharmaceutical PreparationsFiscal year ends December 31
NIKA PHARMACEUTICALS, INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.41+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $431.19M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Nika Pharmaceuticals's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Dimitar Slavchev Savov | CEO, CFO, President, Director, 10% owner | 455,589,500 | 43.32% | Mar 19, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Dimitar Slavchev Savov CEO, CFO, President, Director, 10% owner | Mar 18, 2025 | Sale | −2,000,000 | $0.25 | $500.00K | 455,589,500 |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Jun 2, 2023 | Sale | −3,500,000 | $0.02 | $70.00K | – |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Jan 31, 2023 | Sale | −1,500,000 | $0.01 | $15.00K | – |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Jan 10, 2023 | Sale | −6,300,000 | $0.01 | $63.00K | – |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Oct 24, 2022 | Sale | −3,000,000 | $0.04 | $120.00K | – |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Sep 26, 2022 | Sale | −1,250,000 | $0.02 | $25.00K | – |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Sep 12, 2022 | Sale | −7,000,000 | $0.02 | $140.00K | – |
| Nika Pharmaceuticals, Inc Secretary, Director, 10% owner | Jul 20, 2022 | Other | +145,000,000 | – | – | – |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Jul 20, 2022 | Other | +333,181,000 | – | – | – |
| Nika Pharmaceuticals, Inc Secretary, Director, 10% owner | Apr 29, 2022 | Other | +5,000,000 | $50000.00 | $250.00B | 5,000,000 |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Apr 13, 2022 | Buy | +11,489,000 | $0.01 | $114.89K | – |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Apr 13, 2022 | Other | +10,000,000 | $3000000.00 | $30.00T | 10,000,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Dimitar Slavchev Savov Officer, Director, 10% Stockholder | Apr 16, 2025 | 10,000,000 | $10.00M | Apr 16, 2025 | Stock Purchase Agreement |